Dae Han New Pharm is a finished-dose manufacturer based in South Korea. It appears in 10 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with DAV (Vietnam), ARCSA (EC) and NPRA (MY).
| Regulator | Filings | GMP certificates |
|---|---|---|
| DAV (Vietnam) | 7 | None |
| ARCSA (EC) | 2 | None |
| NPRA (MY) | 1 | None |
Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.
Choose your molecules and target markets. Dae Han New Pharm comes back tiered against every other supplier able to file there.
Start for free